OnKure Therapeutics, Inc.

NASDAQ:OKUR

Biotechnology

Healthcare
$2.82 +0.23%

+$0.01 today

Market cap
$114.22M
Beta
0.28
P/E (TTM)
-1.0
EPS (TTM)
-$4.30
52W Low $1.91High $5.38

Volume 0.17M

Average 0.37M

OKUR Long-term Investments

Investments the company intends to hold for more than a year.

OnKure Therapeutics, Inc.NASDAQ: OKUR

Long-term Investments · Q1 FY2026 · quarter ended Mar 2026

Long-term investments remains negative

Q1 FY2026 long-term investments was $0, compared with $0 a year earlier.

Context

  • Long-term investments amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Long-term investments increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Long-term Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Long-term Investments history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Long-term Investments vs competitors

How OKUR compares with its peers on the latest reported figures

  • OKUR's Mar 2026 long-term investments of $0 is the highest of the 4 companies compared; the peer median is $0.
  • Long-term investments amounts to 0.0% of total assets for OKUR, versus a peer median of 0.0%.
OKUR Competitors Peer median
Long-term Investments for OKUR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OKUROnKure Therapeutics, Inc.Mar 2026$0 ——0.0%
XLOXilio Therapeutics, Inc.Mar 2026$0 -100.0%+5.0%0.0%
ATNMActinium Pharmaceuticals, Inc.Jun 2026$0 -100.0%—0.0%
PDSBPDS Biotechnology CorporationMar 2026$0 ——0.0%
Peer median (excluding OKUR) $0-100.0%+5.0%0.0%

Competitors are the stored peer set for OKUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents124.66M11.54M29.88M110.76M59.05M
Short-term Investments23.01M0000
Net Receivables00000
Inventory00000
Other Current Assets6.06M840K001.79M
Total Current Assets153.73M13.62M33.77M113M60.84M
Property, Plant & Equipment (Net)212K2.05M1.91M1.8M1.01M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets78K329K58K109K273K
Total Non-current Assets290K2.38M1.97M1.9M1.28M
Total Assets154.02M16M35.73M114.91M62.12M
Account Payables02.52M3.42M2.97M1.43M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities6.2M1.46M1.66M3.17M1.25M
Total Current Liabilities6.2M5.54M7.29M10.53M5.92M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)167K0000
Other Non-current Liabilities444K64.39M129.83M012K
Total Non-current Liabilities611K64.88M130.29M549K12K
Total Liabilities6.81M70.42M137.58M11.08M5.93M
Common Stock3K1K01K1K
Retained Earnings(84.73M)(57.07M)(102.05M)(154.72M)(214.24M)
Accumulated OCI34K0000
Other Stockholders Equity00000
Minority Interest00000
Total Equity147.21M(54.42M)(101.84M)103.83M56.18M
Total Debt0637K674K1.09M549K
Net Debt(124.66M)(10.91M)(29.2M)(109.68M)(58.5M)

OnKure Therapeutics, Inc.

NASDAQ:OKUR

Intrinsic Alpha fair value

Locked

Current Price

$2.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.